how does crypto make money searches

Kei Ma quit Xiaomi Home Technology Co., Ltd., and Tianyancha App showed that recently, Xiaomi Home Technology Co., Ltd. underwent industrial and commercial changes, and Kei Ma stepped down as the legal representative and manager. As Peng took over, Lei Jun was changed from an executive director to a director. Xiaomi Home Technology Co., Ltd. was established in January 2017 with a registered capital of RMB 80 million. Its business scope includes communication equipment sales, computer software and hardware and auxiliary equipment wholesale, computer software and hardware and auxiliary equipment retail, shoes and hats wholesale, motorcycles and spare parts wholesale, etc. It is wholly owned by Xiaomi Communication Technology Co., Ltd. According to media reports, recently, Kei Ma, vice president of Xiaomi Group, has left his post, and the news has aroused many concerns.Jiayi Co., Ltd.: It plans to increase capital by 28 million US dollars to set up Vietnam Sun Company. Jiayi Co., Ltd. announced that the company plans to increase capital by 28 million US dollars to its wholly-owned subsidiary Jiayi Singapore with its own funds for the establishment of wholly-owned Sun Company Jiayi Drinking Water Co., Ltd. in Vietnam. This investment aims at expanding overseas production bases, enhancing supply chain flexibility, enhancing core competitiveness and accelerating business internationalization.Senior US official: Russia has provided important assistance to Iran in fighter planes, missile defense and space technology.

Japanese Reuters's short-term non-manufacturing boom judgment index in December is 30, with the previous value of 19; Reuters's short-term judgment index of manufacturing prosperity in December was -1, with the previous value of 5.US Treasury Department: US Treasury Secretary Yellen expressed appreciation for the close communication between the Ministry of Economic Affairs of Korea and the United States after the recent events in South Korea.Hengrui Pharma: HRS-4729 injection was approved for clinical trial. Hengrui Pharma announced that the company and its subsidiary Fujian Sheng Di Pharmaceutical Co., Ltd. received the Notice of Approval for Clinical Trial of HRS-4729 injection approved and issued by National Medical Products Administration. The drug is a polypeptide drug independently developed, and it is a GLP-1R/GIPR/GCGR triple agonist, which is suitable for obese or overweight patients. Up to now, HRS-4729 injection has invested about 19.56 million yuan in research and development.

 *ST Hanma: The reorganization plan of the company and its five subsidiaries was approved by the court. On December 11, 2024, the company and its five subsidiaries, Anhui Valin Automobile Co., Ltd., Anhui Xingma Special Purpose Vehicle Co., Ltd., Anhui Fuma Automobile Parts Group Co., Ltd., Anhui Fuma Electronic Technology Co., Ltd. and Wuhu Fuma Automobile Parts Co., Ltd., received the court ruling, approved their reorganization plans and terminated the reorganization procedures, and then entered the implementation stage.Xia Yiping, CEO of Extreme Vietnam: The company is experiencing difficulties at present, and the company needs to adjust immediately. On December 11th, it was learned from the inside of Extreme Vietnam Automobile that Xia Yiping, CEO of Extreme Vietnam, communicated with all employees through video conference, frankly indicating that the company is experiencing difficulties at present, and the company needs to adjust immediately and enter the 2.0 stage of entrepreneurship. The management will go all out to tide over the difficulties with all employees. Xia Yiping said that in the new entrepreneurial period, the following four things must be done well: 1. Adhere to the long-term investment in core technologies to maintain the leading edge; 2. Strengthen sales and service capacity building to cope with fierce market competition; 3. Merge departments and posts with duplicate functions and change inefficient internal workflow; 4. Reduce projects that cannot improve financial performance in the short term. (Blue Whale Finance)